Abstract
1 Budesonide is an epimeric mixture of a new synthetic non-halogenated glucocorticoid (16 alpha, 17 alpha,-(22R,S)-prophylmethylenedioxypregna-1,4-diene-11/3,21-diol-3, 20-dione). 2 Acute dose response studies with three different inhaled doses of budesonide, have been carried out in a group of 12 chronic asthmatic patients. 3 The lowest dose (100 micrograms) of inhaled budesonide produced a more marked effect in relieving airflow obstruction, than a much larger (1600 micrograms) oral dose of the drug. 4 When the area under the curve for peak expiratory flow rate values was calculated, a dose-response relationship could be seen between the different inhaled doses. 5 It appears that budesonide has a predominantly local anti-asthmatic action in the lung.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agrup G., Björnberg A., Elmros T., Groth O., Hannuksela M., Lassus A., Salde L., Skogh M., Thomsen K. Clinical trial of a potent non-halogenated topical steroid, Budesonide. Acta Derm Venereol. 1981;61(2):180–182. [PubMed] [Google Scholar]
- Balle V. H., Pedersen U., Engby B. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray. Rhinology. 1980 Sep;18(3):135–142. [PubMed] [Google Scholar]
- Ellul-Micallef R., Borthwick R. C., McHardy G. J. The time-course of response to prednisolone in chronic bronchial asthma. Clin Sci Mol Med. 1974 Aug;47(2):105–117. doi: 10.1042/cs0470105. [DOI] [PubMed] [Google Scholar]
- Ellul-Micallef R., Hansson E., Johansson S. A. Budesonide: a new corticosteroid in bronchial asthma. Eur J Respir Dis. 1980 Jun;61(3):167–173. [PubMed] [Google Scholar]
- Ellul-Micallef R., Morén F., Wetterlin K., Hidinger K. C. Use of a special inhaler attachment in asthmatic children. Thorax. 1980 Aug;35(8):620–623. doi: 10.1136/thx.35.8.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godden D. J., Crompton G. K. An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficiently. Br J Dis Chest. 1981 Apr;75(2):165–168. doi: 10.1016/0007-0971(81)90049-8. [DOI] [PubMed] [Google Scholar]
- Hartiala J., Uotila P., Nienstedt W. Absorption and metabolism of intratracheally instilled cortisol and beclomethasone dipropionate in the isolated perfused rat lungs. Med Biol. 1979 Oct;57(5):294–297. [PubMed] [Google Scholar]
- Malm L., Wihl J. A., Lamm C. J., Lindqvist N. Reduction of metacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy. 1981 Apr;36(3):209–214. doi: 10.1111/j.1398-9995.1981.tb01836.x. [DOI] [PubMed] [Google Scholar]
- Martin L. E., Tanner R. J., Clark T. J., Cochrane G. M. Absorption and metabolism of orally administered beclomethsone dipropionate. Clin Pharmacol Ther. 1974 Mar;15(3):267–275. doi: 10.1002/cpt1974153267. [DOI] [PubMed] [Google Scholar]
- Paterson I. C., Crompton G. K. Use of pressurised aerosols by asthmatic patients. Br Med J. 1976 Jan 10;1(6001):76–77. doi: 10.1136/bmj.1.6001.76-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pipkorn U., Rundcrantz H., Lindqvist N. Budesonide - a new nasal steroid. Rhinology. 1980 Dec;18(4):171–175. [PubMed] [Google Scholar]
- SAUNDERS K. B. MISUSE OF INHALED BRONCHODILATOR AGENTS. Br Med J. 1965 Apr 17;1(5441):1037–1038. doi: 10.1136/bmj.1.5441.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thalén A., Brattsand R. Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneimittelforschung. 1979;29(11):1687–1690. [PubMed] [Google Scholar]
- Willey R. F., Godden D. J., Carmichael J., Preston P., Frame M., Crompton G. K. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest. 1982 Jan;76(1):61–68. [PubMed] [Google Scholar]